Table of Contents List of Tables List of Figures Introduction Global Markets Direct Report Coverage Pressure Ulcers - Overview Pressure Ulcers - Therapeutics Development Pipeline Overview Pipeline by Companies Products under Development by Companies Pressure Ulcers - Therapeutics Assessment Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Pressure Ulcers - Companies Involved in Therapeutics Development EyeGene Inc Izun Pharmaceuticals Corp MimeTech Srl NovaLead Pharma Pvt Ltd RegeneRx Biopharmaceuticals Inc Pressure Ulcers - Drug Profiles AG-100 - Drug Profile Product Description Mechanism Of Action R&D Progress EG-Decorin - Drug Profile Product Description Mechanism Of Action R&D Progress IZN-6D4 - Drug Profile Product Description Mechanism Of Action R&D Progress MT-8 - Drug Profile Product Description Mechanism Of Action R&D Progress NLP-328 - Drug Profile Product Description Mechanism Of Action R&D Progress RGN-137 - Drug Profile Product Description Mechanism Of Action R&D Progress Stem Cell Therapy for Pressure Ulcers - Drug Profile Product Description Mechanism Of Action R&D Progress Pressure Ulcers - Dormant Projects Pressure Ulcers - Discontinued Products Pressure Ulcers - Product Development Milestones Featured News & Press Releases Dec 04, 2015: RegeneRx Receives Chinese Patent for Key TB4 Peptide Fragment Jan 09, 2009: RegeneRx Reports Phase II Pressure Ulcer Trial Results Sep 22, 2008: RegeneRx/Sigma-Tau Completes Patient Enrollment Of Second Phase II Clinical Trial With RGN-137 Aug 20, 2008: RegeneRx Completes Patient Enrollment Of First Phase II Clinical Trial Nov 02, 2004: RegeneRx Gets Cleared To Initiate Phase II Clinical Trial With Tß4 For Chronic Pressure Ulcers Appendix Methodology Coverage Secondary Research Primary Research Expert Panel Validation Contact Us Disclaimer

List of Tables Number of Products under Development for Pressure Ulcers, H1 2018 Number of Products under Development by Companies, H1 2018 Products under Development by Companies, H1 2018 Number of Products by Stage and Target, H1 2018 Number of Products by Stage and Mechanism of Action, H1 2018 Number of Products by Stage and Route of Administration, H1 2018 Number of Products by Stage and Molecule Type, H1 2018 Pressure Ulcers - Pipeline by EyeGene Inc, H1 2018 Pressure Ulcers - Pipeline by Izun Pharmaceuticals Corp, H1 2018 Pressure Ulcers - Pipeline by MimeTech Srl, H1 2018 Pressure Ulcers - Pipeline by NovaLead Pharma Pvt Ltd, H1 2018 Pressure Ulcers - Pipeline by RegeneRx Biopharmaceuticals Inc, H1 2018 Pressure Ulcers - Dormant Projects, H1 2018 Pressure Ulcers - Discontinued Products, H1 2018 List of Figures Number of Products under Development for Pressure Ulcers, H1 2018 Number of Products under Development by Companies, H1 2018 Number of Products by Stage and Targets, H1 2018 Number of Products by Stage and Mechanism of Actions, H1 2018 Number of Products by Routes of Administration, H1 2018 Number of Products by Stage and Routes of Administration, H1 2018 Number of Products by Molecule Types, H1 2018 Number of Products by Stage and Molecule Types, H1 2018

EyeGene Inc Izun Pharmaceuticals Corp MimeTech Srl NovaLead Pharma Pvt Ltd RegeneRx Biopharmaceuticals Inc